发明名称 |
TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DÉRIVE |
摘要 |
Phospholipid based powders for drug delivery applications are disclosed. The powders comprise a polyvalent cation in an amount effective to increase the gel-to-liquid crystal transition temperature of the particle compared to particles without the polyvalent cation. The powders are hollow and porous and are preferably administered via inhalation. |
申请公布号 |
LU92678(I2) |
申请公布日期 |
2015.11.02 |
申请号 |
LU20150092678C |
申请日期 |
2015.03.11 |
申请人 |
NOVARTIS AG |
发明人 |
|
分类号 |
A61K47/24;A61K9/00;A61K9/10;A61K9/127;A61K9/14;A61K9/16;A61K38/29;A61K47/02;A61K47/26;A61K47/36;A61M15/00 |
主分类号 |
A61K47/24 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|